U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dobutamine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 11/06/2017
»Therapeutic Categories: Cardiovascular; Pediatric; Renal

Expand all

Baxter Healthcare (Reverified 09/28/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793 Limited Supply on Allocation, Recovery Q4 Third-Party Supplier Issue Third-Party Supplier Issue

Hospira, Inc. (Revised 09/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32) Next Delivery and Estimated Recovery: October 2022 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Other
500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32) Next Delivery: September 2022; Estimated Recovery: October 2022 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Other
1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32) Next Delivery: November 2022; Estimated Recovery: January 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Demand increase for the drug
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20) Discontinued Discontinuation of the manufacture of the drug
500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54) Discontinued Discontinuation of the manufacture of the drug
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01) Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: February 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02) Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: February 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Back to Top